Abstract
Periodontitis refers to a wide range of the inflammatory conditions of supporting dental structures. For some patients with periodontitis, antibacterial agents are needed as an adjuvant to mechanical debridement treatments and oral hygiene maintenance. However, the widespread use of broad-spectrum antibiotics for the prophylaxis and treatment of periodontal infections results in the emergence of resistant pathogens. Therefore, probiotics have become markedly interesting to researchers as a potentially safe alternative to periodontal treatment and maintenance. Probiotics have been used in medicine for decades and extensively applied to the treatment of inflammatory diseases through the modulation of microbial synergy and other mechanisms. A growing amount of evidence has shown that using Lactobacillus strains for oral cavity maintenance could improve periodontal health. In this study, we reviewed studies showing proof of the inhibitory effects of Lactobacillus species on periodontal inflammation. We also explored the rationale and potential for using Lactobacillus species in the management of periodontitis.
Similar content being viewed by others
Change history
27 July 2022
An Erratum to this paper has been published: https://doi.org/10.1007/s12275-022-1681-3
References
Abe-Yutori, M., Chikazawa, T., Shibasaki, K., and Murakami, S. 2017. Decreased expression of E-cadherin by Porphyromonas gingivalislipopolysaccharide attenuates epithelial barrier function. J. Periodontal Res. 52, 42–50.
Albuquerque-Souza, E., Balzarini, D., Ando-Suguimoto, E.S., Ishikawa, K.H., Simionato, M.R.L., Holzhausen, M., and Mayer, M.P.A. 2019. Probiotics alter the immune response of gingival epithelial cells challenged by Porphyromonas gingivalis. J. Periodontal Res. 54, 115–127.
Azad, M.A.K., Sarker, M., Li, T., and Yin, J. 2018. Probiotic species in the modulation of gut microbiota: an overview. BioMed Res. Int. 2018, 9478630.
Azcarate-Peril, M.A., Altermann, E., Goh, Y.J., Tallon, R., Sanozky-Dawes, R.B., Pfeiler, E.A., O'Flaherty, S., Buck, B.L., Dobson, A., Duong, T., et al. 2008. Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. Appl. Environ. Microbiol. 74, 4610–4625.
Chaves de Souza, J.A., Frasnelli, S.C.T., Curylofo-Zotti, F.A., Ávila-Campos, M.J., Spolidório, L.C., Zamboni, D.S., Graves, D.T., and Rossa, C. 2016. NOD1 in the modulation of host-microbe interactions and inflammatory bone resorption in the periodontal disease model. Immunology 149, 374–385.
Chen, L., Zou, Y., Peng, J., Lu, F., Yin, Y., Li, F., and Yang, J. 2015. Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis. J. Immunol. Res. 2015, 909514.
Collins, F.L., Rios-Arce, N.D., Schepper, J.D., Parameswaran, N., and McCabe, L.R. 2017. The potential of probiotics as a therapy for osteoporosis. Microbiol. Spect. 5. doi:https://doi.org/10.1128/microbiolspec.BAD-0015-2016.
Cornacchione, L.P., Klein, B.A., Duncan, M.J., and Hu, L.T. 2019. Interspecies inhibition of Porphyromonas gingivalis by yogurtderived Lactobacillus delbrueckii requires active pyruvate oxidase. Appl. Environ. Microbiol. 85, e01271–19.
Daghigh, F., Borghaei, R.C., Thornton, R.D., and Bee, J.H. 2002. Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. J. Periodontol. 73, 392–400.
Díaz, C.M., Bullon, B., Ruiz-Salmerón, R.J., Fernández-Riejos, P., Fernández-Palacín, A., Battino, M., Cordero, M.D., Quiles, J.L., Varela-López, A., and Bullón, P. 2020. Molecular inflammation and oxidative stress are shared mechanisms involved in both myocardial infarction and periodontitis. J. Periodontal Res. 55, 519–528.
Eke, P.I., Borgnakke, W.S., and Genco, R.J. 2020. Recent epidemiologic trends in periodontitis in the USA. Periodontol. 2000 82, 257–267.
Gibson, G.R., Hutkins, R., Sanders, M.E., Prescott, S.L., Reimer, R.A., Salminen, S.J., Scott, K., Stanton, C., Swanson, K.S., Cani, P.D., et al. 2017. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 14, 491–502.
Gillor, O., Etzion, A., and Riley, M.A. 2008. The dual role of bacteriocins as anti- and probiotics. Appl. Microbiol. Biotechnol. 81, 591–606.
Goldstein, E.J.C., Tyrrell, K.L., and Citron, D.M. 2015. Lactobacillus species: taxonomic complexity and controversial susceptibilities. Clin. Infect. Dis. 60, S98–S107.
Gordon, D.M. 2009. The potential of bacteriocin-producing probiotics and associated caveats. Future Microbiol. 4, 941–943.
Grusovin, M.G., Bossini, S., Calza, S., Cappa, V., Garzetti, G., Scotti, E., Gherlone, E.F., and Mensi, M. 2020. Clinical efficacy of Lactobacillus reuteri-containing lozenges in the supportive therapy of generalized periodontitis stage III and IV, grade C: 1-year results of a double-blind randomized placebo-controlled pilot study. Clin. Oral Investig. 24, 2015–2024.
Gupta, G. 2011. Probiotics and periodontal health. J. Med. Life 4, 387–394.
Hajishengallis, G. 2015. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 15, 30–44.
Hajishengallis, G. and Lamont, R.J. 2012. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol. Oral Microbiol. 27, 409–419.
Hajishengallis, G. and Lamont, R.J. 2014. Breaking bad: manipulation of the host response by Porphyromonas gingivalis. Eur. J. Immunol. 44, 328–338.
Hallström, H., Lindgren, S., Yucel-Lindberg, T., Dahlén, G., Renvert, S., and Twetman, S. 2013. Effect of probiotic lozenges on inflammatory reactions and oral biofilm during experimental gingivitis. Acta Odontol. Scand. 71, 828–833.
He, M. and Shi, B. 2017. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci. 7, 54.
Heitz-Mayfield, L.J.A. and Lang, N.P. 2013. Surgical and nonsurgical periodontal therapy. Learned and unlearned concepts. Periodontol. 2000 62, 218–231.
Hoare, A., Marsh, P.D., and Diaz, P.I. 2017. Ecological therapeutic opportunities for oral diseases. Microbiol. Spect. 5. doi:https://doi.org/10.1128/microbiolspec.BAD-0006-2016.
Holt, S.C. and Ebersole, J.L. 2005. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol. 2000 38, 72–122.
Ince, G., Gürsoy, H., Ipçi, S.D., Cakar, G., Emekli-Alturfan, E., and Yilmaz, S. 2015. Clinical and biochemical evaluation of lozenges containing Lactobacillus reuteri as an adjunct to non-surgical periodontal therapy in chronic periodontitis. J. Periodontol. 86, 746–754.
Ishikawa, K.H., Mita, D., Kawamoto, D., Nicoli, J.R., Albuquerque-Souza, E., Lorenzetti Simionato, M.R., and Mayer, M.P.A. 2020. Probiotics alter biofilm formation and the transcription of Porphyromonas gingivalis virulence-associated genes. J. Oral Microbiol. 12, 1805553.
Jaffar, N., Ishikawa, Y., Mizuno, K., Okinaga, T., and Maeda, T. 2016. Mature biofilm degradation by potential probiotics: Aggregatibacter actinomycetemcomitans versus Lactobacillus spp. PLoS ONE 11, e0159466.
Janczarek, M., Bachanek, T., Mazur, E., and Chalas, R. 2016. The role of probiotics in prevention of oral diseases. Postepy Hig. Med. Dosw. 70, 850–857.
Karpinski, T.M. and Szkaradkiewicz, A.K. 2016. Bacteriocins. In Finglas, P.M. and Toldrá, F. (eds.), Encyclopedia of Food and Health, pp. 312–319. Academic Press, Waltham, Massachusetts, USA.
Keller, M.K., Hasslöf, P., Stecksén-Blicks, C., and Twetman, S. 2011. Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study. Acta Odontol. Scand. 69, 263–268.
Khalaf, H., Nakka, S.S., Sandén, C., Svärd, A., Hultenby, K., Scherbak, N., Aili, D., and Bengtsson, T. 2016. Antibacterial effects of Lactobacillus and bacteriocin PLNC8 aβ on the periodontal pathogen Porphyromonas gingivalis. BMC Microbiol. 16, 188.
Kinane, D.F., Stathopoulou, P.G., and Papapanou, P.N. 2017. Periodontal diseases. Nat. Rev. Dis. Primers 3, 17038.
Kobatake, E., Kobayashi, R., Kabuki, T., and Kurita-Ochiai, T. 2019. Lactobacillus helveticus SBT2171 upregulates the expression of β-defensin and ameliorates periodontal disease caused by Porphyromonas gingivalis. Microbiol. Immunol. 63, 293–302.
Kõll-Klais, P., Mändar, R., Leibur, E., Marcotte, H., Hammarström, L., and Mikelsaar, M., 2005. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol. Immunol. 20, 354–361.
Komine, K., Kuroishi, T., Ozawa, A., Komine, Y., Minami, T., Shimauchi, H., and Sugawara, S. 2007. Cleaved inflammatory lactoferrin peptides in parotid saliva of periodontitis patients. Mol. Immunol. 44, 1498–1508.
Krasse, P., Carlsson, B., Dahl, C., Paulsson, A., Nilsson, A., and Sinkiewicz, G. 2006. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed. Dent. J. 30, 55–60.
Laleman, I., Pauwels, M., Quirynen, M., and Teughels, W. 2020. A dual-strain Lactobacilli reuteri probiotic improves the treatment of residual pockets: a randomized controlled clinical trial. J. Clin. Periodontol. 47, 43–53.
Laleman, I. and Teughels, W. 2015. Probiotics in the dental practice: a review. Quintessence Int. 46, 255–264.
Lamont, R.J., Koo, H., and Hajishengallis, G. 2018. The oral microbiota: dynamic communities and host interactions. Nat. Rev. Microbiol. 16, 745–759.
Lee, G., Kim, H.J., and Kim, H.M. 2016. RhoA-JNK regulates the E-cadherin junctions of human gingival epithelial cells. J. Dent. Res. 95, 284–291.
Liu, H., Gu, R., Li, W., Xue, J., Cong, Z., Wei, Q., and Zhou, Y. 2020. Probiotics protect against tenofovir-induced mandibular bone loss in mice by rescuing mandible-derived mesenchymal stem cell proliferation and osteogenic differentiation. J. Oral Rehabil. 47, 83–90.
Loboda, A., Damulewicz, M., Pyza, E., Jozkowicz, A., and Dulak, J. 2016. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell. Mol. Life Sci. 73, 3221–3247.
López-López, A., Camelo-Castillo, A., Ferrer, M.D., Simon-Soro, Á., and Mira, A. 2017. Health-associated niche inhabitants as oral probiotics: the case of Streptococcus dentisani. Front. Microbiol. 8, 379.
Maekawa, T. and Hajishengallis, G. 2014. Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss. J. Periodontal Res. 49, 785–791.
Mahdhi, A., Leban, N., Chakroun, I., Chaouch, M.A., Hafsa, J., Fdhila, K., Mahdouani, K., and Majdoub, H. 2017. Extracellular polysaccharide derived from potential probiotic strain with antioxidant and antibacterial activities as a prebiotic agent to control pathogenic bacterial biofilm formation. Microb. Pathog. 109, 214–220.
Marsh, P.D. 1994. Microbial ecology of dental plaque and its significance in health and disease. Adv. Dent. Res. 8, 263–271.
Marsh, P.D. 2015. The commensal microbiota and the development of human disease - an introduction. J. Oral Microbiol. 7, 29128.
Mendi, A. and Aslim, B. 2014. Antioxidant lactobacilli could protect gingival fibroblasts against hydrogen peroxide: a preliminary in vitro study. Probiotics Antimicrob. Proteins 6, 157–164.
Moens, E. and Veldhoen, M. 2012. Epithelial barrier biology: good fences make good neighbours. Immunology 135, 1–8.
Montero, E., Iniesta, M., Rodrigo, M., Marín, M.J., Figuero, E., Herrera, D., and Sanz, M. 2017. Clinical and microbiological effects of the adjunctive use of probiotics in the treatment of gingivitis: a randomized controlled clinical trial. J. Clin. Periodontol. 44, 708–716.
Morales, A., Gandolfo, A., Bravo, J., Carvajal, P., Silva, N., Godoy, C., Garcia-Sesnich, J., Hoare, A., Diaz, P., and Gamonal, J. 2018. Microbiological and clinical effects of probiotics and antibiotics on nonsurgical treatment of chronic periodontitis: a randomized placebo-controlled trial with 9-month follow-up. J. Appl. Oral Sci. 26, e20170075.
Nagarakanti, S., Ramya, S., Babu, P., Arun, K.V., and Sudarsan, S. 2007. Differential expression of E-cadherin and cytokeratin 19 and net proliferative rate of gingival keratinocytes in oral epithelium in periodontal health and disease. J. Periodontol. 78, 2197–2202.
Naito, Y., Takagi, T., Uchiyama, K., and Yoshikawa, T. 2011. Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases. J. Clin. Biochem. Nutr. 48, 126–133.
Nart, J., Jiménez-Garrido, S., Ramírez-Sebastià, A., Astó, E., Buj, D., Huedo, P., and Espadaler, J. 2021. Oral colonization by Levilactobacillus brevis KABPTM-052 and Lactiplantibacillus plantarum KABPTM-051: a randomized, double-blinded, placebo-controlled trial (pilot study). J. Clin. Exp. Dent. 13, e433–e439.
Page, R.C., Offenbacher, S., Schroeder, H.E., Seymour, G.J., and Kornman, K.S. 1997. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 14, 216–248.
Pangsomboon, K., Bansal, S., Martin, G.P., Suntinanalert, P., Kaewnopparat, S., and Srichana, T. 2009. Further characterization of a bacteriocin produced by Lactobacillus paracasei HL32. J. Appl. Microbiol. 106, 1928–1940.
Park, J.S., Choi, J.W., Jhun, J., Kwon, J.Y., Lee, B.I., Yang, C.W., Park, S.H., and Cho, M.L. 2018. Lactobacillus acidophilus improves intestinal inflammation in an acute colitis mouse model by regulation of Th17 and Treg Cell balance and fibrosis development. J. Med. Food 21, 215–224.
Pelekos, G., Ho, S.N., Acharya, A., Leung, W.K., and McGrath, C. 2019. A double-blind, paralleled-arm, placebo-controlled and randomized clinical trial of the effectiveness of probiotics as an adjunct in periodontal care. J. Clin. Periodontol. 46, 1217–1227.
Piwat, S., Sophatha, B., and Teanpaisan, R. 2015. An assessment of adhesion, aggregation and surface charges of Lactobacillus strains derived from the human oral cavity. Lett. Appl. Microbiol. 61, 98–105.
Pudgar, P., Povšic, K., Cuk, K., Seme, K., Petelin, M., and Gašperšic, R. 2021. Probiotic strains of Lactobacillus brevis and Lactobacillus plantarum as adjunct to non-surgical periodontal therapy: 3-month results of a randomized controlled clinical trial. Clin. Inhibitory effects of Lactobacillus on periodontitis 363 Oral. Investig. 25, 1411–1422.
Reynolds, J.J. 1996. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis. 2, 70–76.
Riccia, D.N.D., Bizzini, F., Perilli, M.G., Polimeni, A., Trinchieri, V., Amicosante, G., and Cifone, M.G. 2007. Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Dis. 13, 376–385.
Rosier, B.T., Marsh, P.D., and Mira, A. 2018. Resilience of the oral microbiota in health: mechanisms that prevent dysbiosis. J. Dent. Res. 97, 371–380.
Saglam, M., Kantarci, A., Dundar, N., and Hakki, S.S. 2014. Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: a randomized, controlled clinical trial. Lasers Med. Sci. 29, 37–46.
Saha, S., Tomaro-Duchesneau, C., Rodes, L., Malhotra, M., Tabrizian, M., and Prakash, S. 2014. Investigation of probiotic bacteria as dental caries and periodontal disease biotherapeutics. Benef. Microbes 5, 447–460.
Sajedinejad, N., Paknejad, M., Houshmand, B., Sharafi, H., Jelodar, R., Shahbani Zahiri, H., and Noghabi, K.A. 2018. Lactobacillus salivarius NK02: a Potent probiotic for clinical application in mouthwash. Probiotics Antimicrob. Proteins 10, 485–495.
Seminario-Amez, M., López-López, J., Estrugo-Devesa, A., Ayuso-Montero, R., and Jané-Salas, E. 2017. Probiotics and oral health: a systematic review. Med. Oral Patol. Oral Cir. Bucal 22, e282–e288.
Shah, M.P., Gujjari, S.K., and Chandrasekhar, V.S. 2013. Evaluation of the effect of probiotic (inersan??) alone, combination of probiotic with doxycycline and doxycycline alone on aggressive periodontitis - a clinical and microbiological study. J. Clin. Diagn. Res. 7, 595–600.
Shimauchi, H., Mayanagi, G., Nakaya, S., Minamibuchi, M., Ito, Y., Yamaki, K., and Hirata, H. 2008. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. J. Clin. Periodontol. 35, 897–905.
Sookkhee, S., Chulasiri, M., and Prachyabrued, W. 2001. Lactic acid bacteria from healthy oral cavity of Thai volunteers: inhibition of oral pathogens. J. Appl. Microbiol. 90, 172–179.
Sulijaya, B., Takahashi, N., and Yamazaki, K. 2019a. Host modulation therapy using anti-inflammatory and antioxidant agents in periodontitis: a review to a clinical translation. Arch. Oral Biol. 105, 72–80.
Sulijaya, B., Yamada-Hara, M., Yokoji-Takeuchi, M., Matsuda-Matsukawa, Y., Yamazaki, K., Matsugishi, A., Tsuzuno, T., Sato, K., Aoki-Nonaka, Y., Takahashi, N., et al. 2019b. Antimicrobial function of the polyunsaturated fatty acid KetoC in an experimental model of periodontitis. J. Periodontol. 90, 1470–1480.
Suzuki, N., Tanabe, K., Takeshita, T., Yoneda, M., Iwamoto, T., Oshiro, S., Yamashita, Y., and Hirofuji, T. 2012. Effects of oil drops containing Lactobacillus salivarius WB21 on periodontal health and oral microbiota producing volatile sulfur compounds. J. Breath Res. 6, 017106.
Szkaradkiewicz, A.K., Stopa, J., and Karpinski, T.M. 2014. Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis. Arch. Immunol. Ther. Exp. 62, 495–500.
Tekce, M., Ince, G., Gursoy, H., Dirikan Ipci, S., Cakar, G., Kadir, T., and Yilmaz, S. 2015. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study. J. Clin. Periodontol. 42, 363–372.
Teughels, W., Durukan, A., Ozcelik, O., Pauwels, M., Quirynen, M., and Haytac, M.C. 2013. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. J. Clin. Periodontol. 40, 1025–1035.
Teughels, W., Loozen, G., and Quirynen, M. 2011. Do probiotics offer opportunities to manipulate the periodontal oral microbiota? J. Clin. Periodontol. 38, 159–177.
Theodoro, L.H., Cláudio, M.M., Nuernberg, M.A.A., Miessi, D.M.J., Batista, J.A., Duque, C., and Garcia, V.G. 2019. Effects of Lactobacillus reuteri as an adjunct to the treatment of periodontitis in smokers: randomised clinical trial. Benef. Microbes 10, 375–384.
Tobita, K., Watanabe, I., Tomokiyo, M., and Saito, M. 2018. Effects of heat-treated Lactobacillus crispatus KT-11 strain consumption on improvement of oral cavity environment: a randomised double-blind clinical trial. Benef. Microbes 9, 585–592.
Tözüm, T.F., Yildirim, A., Caglayan, F., Dinçel, A., and Bozkurt, A. 2004. Serum and gingival crevicular fluid levels of ciprofloxacin in patients with periodontitis. J. Am. Dent. Assoc. 135, 1728–1732.
Tsai, Y.L., Lin, T.L., Chang, C.J., Wu, T.R., Lai, W.F., Lu, C.C., and Lai, H.C. 2019. Probiotics, prebiotics and amelioration of diseases. J. Biomed. Sci. 26, 3.
Tüter, G., Serdar, M., Kurtis, B., Walker, S.G., Atak, A., Toyman, U., Pinar, S., and Aykan, T. 2010. Effects of scaling and root planing and subantimicrobial dose doxycycline on gingival crevicular fluid levels of matrix metalloproteinase-8, -13 and serum levels of HsCRP in patients with chronic periodontitis. J. Periodontol. 81, 1132–1139.
Vicario, M., Santos, A., Violant, D., Nart, J., and Giner, L. 2013. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial. Acta Odontol. Scand. 71, 813–819.
Vivekananda, M.R., Vandana, K.L., and Bhat, K.G. 2010. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. J. Oral Microbiol. 2, 5344.
Wang, Y., Andrukhov, O., and Rausch-Fan, X. 2017. Oxidative stress and antioxidant system in periodontitis. Front. Physiol. 8, 910.
Xu, H., Jeong, H.S., Lee, H.Y., and Ahn, J. 2009. Assessment of cell surface properties and adhesion potential of selected probiotic strains. Lett. Appl. Microbiol. 49, 434–442.
Xue, L., He, J., Gao, N., Lu, X., Li, M., Wu, X., Liu, Z., Jin, Y., Liu, J., Xu, J., et al. 2017. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. Sci. Rep. 7, 45176.
Yamada, M., Takahashi, N., Matsuda, Y., Sato, K., Yokoji, M., Sulijaya, B., Maekawa, T., Ushiki, T., Mikami, Y., Hayatsu, M., et al. 2018. A bacterial metabolite ameliorates periodontal pathogeninduced gingival epithelial barrier disruption via GPR40 signaling. Sci. Rep. 8, 9008.
Ye, P., Chapple, C.C., Kumar, R.K., and Hunter, N. 2000. Expression patterns of E-cadherin, involucrin, and connexin gap junction proteins in the lining epithelia of inflamed gingiva. J. Pathol. 192, 58–66.
Yokoji-Takeuchi, M., Takahashi, N., Yamada-Hara, M., Sulijaya, B., Tsuzuno, T., Aoki-Nonaka, Y., Tabeta, K., Kishino, S., Ogawa, J., and Yamazaki, K. 2020. A bacterial metabolite induces Nrf2-mediated anti-oxidative responses in gingival epithelial cells by activating the MAPK signaling pathway. Arch. Oral Biol. 110, 104602.
Zhao, J., Feng, X., Zhang, X., and Le, K. 2012. Effect of Porphyromonas gingivalis and Lactobacillus acidophilus on secretion of IL1B, IL6, and IL8 by gingival epithelial cells. Inflammation 35, 1330–1337.
Acknowledgements
This research was funded by Natural Science Foundation of Liaoning Province (20180551232) and Science and Technology Project of Shenyang (F16-102-4-00).
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of Interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Wang, J., Liu, Y., Wang, W. et al. The rationale and potential for using Lactobacillus in the management of periodontitis. J Microbiol. 60, 355–363 (2022). https://doi.org/10.1007/s12275-022-1514-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-022-1514-4